These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 108746)

  • 21. Conditioned aversion to saccharin by single administrations of mescaline and d-amphetamine.
    Cappell H; LeBlanc AE
    Psychopharmacologia; 1971; 22(4):352-6. PubMed ID: 5133436
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of d- and l-amphetamine on dorsal and ventral hypothalamic self-stimulation in three inbred strains of mice.
    Cazala P
    Pharmacol Biochem Behav; 1976 Nov; 5(5):505-10. PubMed ID: 1019180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-site strain comparison of pharmacological deficits in the touchscreen visual discrimination test.
    Mohler EG; Ding Z; Rueter LE; Chapin D; Young D; Kozak R
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4033-41. PubMed ID: 26177580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facilitation of simultaneous visual discrimination by nicotine in four "inbred" strains of mice.
    Bovet-Nitti F
    Psychopharmacologia; 1969; 14(3):193-9. PubMed ID: 5351860
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of LSD-25 on avoidance behavior and locomotor activity in mice.
    Castellano C
    Psychopharmacology (Berl); 1979 Apr; 62(2):145-9. PubMed ID: 111278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a force-plate actometer for detecting and quantifying vertical leaping induced by amphetamine in BALB/cJ mice, but not in C57BL/6J, DBA/2J, 129X1/SvJ, C3H/HeJ, and CD-1 mice.
    McKerchar TL; Zarcone TJ; Fowler SC
    J Neurosci Methods; 2006 May; 153(1):48-54. PubMed ID: 16290200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons.
    Penington NJ; Reiffenstein RJ
    Eur J Pharmacol; 1986 Apr; 122(3):373-7. PubMed ID: 3709659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychoactive compounds and audiogenic seizure susceptibility.
    Boggan WO
    Life Sci; 1973 Jul; 13(2):151-9. PubMed ID: 4751412
    [No Abstract]   [Full Text] [Related]  

  • 29. Facilitation of discrimination transfers under amphetamine: the relative control by S+ and S- and general transfer effects.
    Weiner I; Feldon J; Ben-Horin E
    Psychopharmacology (Berl); 1987; 93(2):261-7. PubMed ID: 3122260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.
    Kollins SH; Rush CR
    Pharmacol Biochem Behav; 1999 Oct; 64(2):319-26. PubMed ID: 10515308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties.
    Nielsen EB; Lee TH; Ellison G
    Psychopharmacology (Berl); 1980; 68(2):197-200. PubMed ID: 6776566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strain differences in amphetamine sensitivity in mice. II. Overcompensation of paradoxical sleep after deprivation in two C57 strains.
    Kitahama K; Valatx JL
    Psychopharmacology (Berl); 1979; 66(3):291-5. PubMed ID: 231278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphine, mescaline and cocaine on water maze discrimination in mice.
    Castellano C
    Psychopharmacologia; 1973 Jan; 28(2):147-53. PubMed ID: 4694623
    [No Abstract]   [Full Text] [Related]  

  • 34. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversal and nonreversal shifts under amphetamine.
    Weiner I; Feldon J
    Psychopharmacology (Berl); 1986; 89(3):355-9. PubMed ID: 3088663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.
    Silverman PB; Ho BT
    Psychopharmacology (Berl); 1980; 68(3):209-15. PubMed ID: 6771804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine.
    Bensadoun JC; Brooks SP; Dunnett SB
    Psychopharmacology (Berl); 2004 Jul; 174(3):396-405. PubMed ID: 14985934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.
    Vaupel DB; Nozaki M; Martin WR; Bright LD; Morton EC
    Life Sci; 1979 Jun; 24(26):2427-31. PubMed ID: 481115
    [No Abstract]   [Full Text] [Related]  

  • 39. Facilitating effects of pre- and posttrial amphetamine administration on discrimination learning in mice.
    Krivanek JA; McGaugh JL
    Agents Actions; 1969 Nov; 1(2):36-42. PubMed ID: 5406195
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of serotonin in the discriminative stimulus properties of mescaline.
    Browne RG; Ho BT
    Pharmacol Biochem Behav; 1975; 3(3):429-35. PubMed ID: 125425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.